US Stock MarketDetailed Quotes

CORT Corcept Therapeutics

Watchlist

73.230
+2.280+3.21%

Close Apr 29 16:00 ET

74.230
+1.000+1.37%

Pre 08:00 ET

7.77BMarket Cap59.54P/E (TTM)

Corcept Therapeutics Stock Forum

Moomoo MY

Apr 9 14:45

Weekly Leaderboard: The Paper Trading Countdown is ON! 🚀

💡 As we wrap up Week 5 of our Paper Trading Competition, the markets are buzzing with unprecedented volatility! Donald Trump's recent announcement of "reciprocal tariffs" has sent shockwaves through global markets, creating a perfect storm for traders to test their mettle! Click here to join now>>
🌊 Riding the Waves of Market Turbulence
Last week's top performer achieved a staggering 59.33% return! How's that for paper profits in these cho...

255

154

Teddy123

Apr 7 20:17

Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer

$Corcept Therapeutics (CORT.US)$
Breakthrough Ovarian Cancer Trial Combines Three Powerful Treatments in Phase 2 Study

That-guy

Apr 2 21:55

$Corcept Therapeutics (CORT.US)$
run while you still have profit

Bunny9819

Apr 1 20:59

$Corcept Therapeutics (CORT.US)$ update ???

That-guy

Apr 1 03:30

$Corcept Therapeutics (CORT.US)$
how is the price going up ?? if the money is going out ?

Be a voice no echo

Apr 1 00:20

no more

$Corcept Therapeutics (CORT.US)$

Hitarthbhatt

Mar 31 22:13

$Corcept Therapeutics (CORT.US)$ Hi can someone please explain how the stock price changed. pre market it was around 1.20 and now it's 100 usd. If I owned some shares would it be worth 100 each, I'm not sure how this works.

10baggerbamm

Mar 31 20:53

$Corcept Therapeutics (CORT.US)$ good grief could you imagine being the person that just shorted this on Friday because it was a cliffhanger ready to break support and gap down dramatically..
holy cow you just got your head ripped off

Movers and Shakers

Mar 31 20:37

Columns Today's Pre-Market Movers and Top Ratings | TSLA, COOP, HUT and more

Morning Movers
Gapping Up
$Corcept Therapeutics (CORT.US)$ surged over 60% after the company announced that its Phase 3 trial, ROSELLA, met its primary endpoint, improving progression-free survival in platinum-resistant ovarian cancer patients.
$QuantaSing Group (QSG.US)$ surged 20.18% in pre-market trading following a 12% increase on Friday. Last week, QuantaSing Group expanded into the pop toys market through the strategic acqui...